PPAR γ Antibodies

Santa Cruz Biotechnology offers a broad range of PPAR γ monoclonal antibodies for research focused on understanding peroxisome proliferator-activated receptor gamma. PPAR γ Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PPAR γ (Peroxisome Proliferator-Activated Receptor Gamma) functions as a key regulator of adipocyte differentiation and glucose metabolism, playing a significant role in lipid metabolism and insulin sensitivity. The influence of PPAR γ extends to various physiological processes, including inflammation and cellular differentiation, making it a crucial target for research in metabolic disorders and obesity. Understanding PPAR γ mechanisms can provide insights into therapeutic strategies for conditions such as type 2 diabetes and cardiovascular diseases. Research has shown that PPAR γ activation can improve insulin sensitivity and reduce inflammation in adipose tissue. Recent studies have highlighted PPAR γ's potential role in cancer biology and immune system regulation. PPAR γ research continues to reveal new pathways and mechanisms in cellular metabolism and disease progression. Santa Cruz Biotechnology monoclonal antibodies for PPAR γ enable researchers worldwide to advance scientific understanding of metabolic diseases and potential therapeutic approaches.